Theolytics

Abalos Therapeutics

This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.

Oncorus

This company develops intravenous self-amplifying RNA medicines and viral immunotherapies for patients with solid tumours.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Neobe

The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.

Xilio Therapeutics

This biotechnology company develops tumour-activated immuno-oncology therapies designed to treat patients with solid cancers while reducing systemic side effects.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Humane Genomics

This company develops synthetic oncolytic viral therapies to treat cancer patients by engineering viruses that selectively infect and destroy malignant cells.